A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918.
Recruiting · NCT05773586 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918. | Hemic and Lymphatic Diseases, anemia, hematologic disorder | Recruiting | Phase 1 | 2026-04-15 | NCT05773586 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ascentage Pharma Group Inc. | 30 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nanfang Hospital of Southern Medical University | Guangzhou | China | 37 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 61 |